Zoetis Inc. (NYSE: ZTS) is a large market cap stock with a market cap of 24820.22. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of 65.68, a forward P/E of 21.66 and EPS of 0.76. At a stock price of 49.35 (-0.73%) it has a dividend yield of 0.76%.
EPS growth for the last five years have been 25.10%, more recently this last year it has grown by -41.90%. The next year growth is going to be about 23.04% and more long-term 12.58% after five years. EPS growth quarter over quarter is 25.00%. Sales growth for the past five years have been 5.90% and sales growth quarter over quarter is 5.40%.
For performance, Zoetis Inc. the past week has seen a gain of 2.96%. For the last month performance for Zoetis Inc. is 5.43%. While the last quarter is 2.58% and half year, 15.35%. Finally for the year, performance is 5.06%.
The 52-week high for Zoetis Inc., is at -1.82%, and for the 52-week low it comes to a value of 31.89%. The 20-day simple moving average is 4.16% and 9.66% for the 200-day simple moving average.
Volatility for the week is at 1.27%, and for the month it is 1.56%. Zoetis Inc., has a target price of 52.7.
In terms of debt, long term debt/equity is 3.83, and for total debt/equity Zoetis Inc. has 3.84. The gross margin is 64.10%, while operating margin is 13.40%, the profit margin is 7.80%. The current ratio is 2.8 and the quick ratio is 1.6.
Insider ownership is at 0.01%, with instituitional ownership at 91.60%. Zoetis Inc. has a payout ratio of 46.90%. With the total shares outstanding coming to 499.2. The shares float is 495.81, with the float short at 1.36%, with short ratio coming to 2.01.
In terms of returns, the return on assets see Zoetis Inc., get 5.30%, with its returns on investment at 5.70%. Return on equity is 32.60%. So will the investors see the target price of 52.7, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.